Delamanid

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

一种分枝菌酸生物合成抑制剂，被发现无致突变性，并且具有高效的抗结核活性。

A mycolic acid biosynthesis inhibitor found to be free of mutagenicity and to possess highly potent activity against tuberculosis, including MDR-TB; shows MIC of 0.006-0.024 ug/mL in vitro and highly effective therapeutic activity at low doses in vivo.

——

——

OPC67683 | OPC-67683 | OPC 67683

GPCR/G Protein

Antibacterial

Antifection

Infection

——

681492-22-8

534.4844

C25H25F3N4O6

>98% (HPLC)

DMSO: ≥ 30 mg/mL

FC(F)(F)OC1=CC=C(OC2CCN(C3=CC=C(OC[C@@]4(C)CN5C(O4)=NC([N+]([O-])=O)=C5)C=C3)CC2)C=C1

Imidazo[2,1-b]oxazole, 2,3-dihydro-2-methyl-6-nitro-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidinyl]phenoxy]methyl]-, (2R)-

(-20℃)

With Ice Pack

≥ 2 years